InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Explore the complete record of transactions filed by Durgam Suresh K., Directeur Médical. Officer active across 1 companies, notably Intra-Cellular Therapies, Inc.. In total, 7 disclosures have been published. Total volume traded: €672k. The latest transaction was filed on 2 March 2022 — Cession. Regulator: SEC (Form 4). All data is free.
Declarations7 total
€213,7884,177 shares@ €51.182331.8% of flow
Common Stock
SEC:0001209191-22-016447:0·
7,906 shares
Common Stock
SEC:0001209191-22-013363:0·
8,354 shares
Common Stock
SEC:0001209191-22-012396:0·
€229,2206,223 shares@ €36.8343100.0% of flow
Common Stock
SEC:0001209191-22-004015·
€229,2206,223 shares@ €36.834334.1% of flow
Common Stock
SEC:0001209191-22-004015:0·
13,093 shares
Common Stock
SEC:0001209191-22-002993·
13,093 shares
Common Stock
SEC:0001209191-22-002993:0·
7 of 7 declarations
About Durgam Suresh K.
Suresh K. Durgam is the Chief Medical Officer at Intra-Cellular Therapies, Inc. In this role, he oversees the company's clinical and research activities, ensuring that the products developed meet safety and efficacy standards. Suresh plays a key role in guiding the strategic direction of research and development initiatives. His medical expertise is essential for the success of the organization's clinical projects.
